Jeffrey S. Weber, MD, PhD: The other difficult discussion is the stage IIIa patients.
Video Reports
Melanoma: BRAF Status and a Neoadjuvant Therapy Approach
Sanjiv S. Agarwala, MD: Hello, and thank you for joining this OncLive Peer Exchange® titled “Expert Perspectives on the Treatment of Melanoma.”
Stage III Melanoma: Neoadjuvant Therapy
Jeffrey S. Weber, MD, PhD: Talking about personalizing, which is sort of the hot topic in melanoma, locoregional treatment is the issue of neoadjuvant therapy.
Neoadjuvant Therapy in the Treatment of Melanoma
Source: OncLive, August 2019 Sanjiv S. Agarwala, MD: Dirk Schadendorf, I’d like to ask you specifically about 1 very interesting aspect with the combination of neoadjuvant T-VEC [talimogene laherparevec] and the…
Read More